OneMedNet Corporation (ONMD)
OneMedNet Statistics
Share Statistics
OneMedNet has 30.76M shares outstanding. The number of shares has increased by 17.35% in one year.
| Shares Outstanding | 30.76M |
| Shares Change (YoY) | 17.35% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 17.6M |
| Failed to Deliver (FTD) Shares | 8.56K |
| FTD / Avg. Volume | 15.56% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -3.77 and the forward PE ratio is null. OneMedNet's PEG ratio is 0.04.
| PE Ratio | -3.77 |
| Forward PE | n/a |
| PS Ratio | 59.38 |
| Forward PS | n/a |
| PB Ratio | -2.39 |
| P/FCF Ratio | -5.43 |
| PEG Ratio | 0.04 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for OneMedNet.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.19, with a Debt / Equity ratio of -0.55.
| Current Ratio | 0.19 |
| Quick Ratio | 0.19 |
| Debt / Equity | -0.55 |
| Debt / EBITDA | -0.91 |
| Debt / FCF | -1.25 |
| Interest Coverage | -65.34 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $29.23K |
| Profits Per Employee | $-460.41K |
| Employee Count | 22 |
| Asset Turnover | 0.17 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 2K |
| Effective Tax Rate | -0.02% |
Stock Price Statistics
The stock price has increased by -30.91% in the last 52 weeks. The beta is 0.72, so OneMedNet's price volatility has been higher than the market average.
| Beta | 0.72 |
| 52-Week Price Change | -30.91% |
| 50-Day Moving Average | 0.63 |
| 200-Day Moving Average | 0.88 |
| Relative Strength Index (RSI) | 32.88 |
| Average Volume (20 Days) | 55.05K |
Income Statement
In the last 12 months, OneMedNet had revenue of 643K and earned -10.13M in profits. Earnings per share was -0.36.
| Revenue | 643K |
| Gross Profit | -281K |
| Operating Income | -9.61M |
| Net Income | -10.13M |
| EBITDA | -9.61M |
| EBIT | -9.98M |
| Earnings Per Share (EPS) | -0.36 |
Balance Sheet
The company has 172K in cash and 8.76M in debt, giving a net cash position of -8.59M.
| Cash & Cash Equivalents | 172K |
| Total Debt | 8.76M |
| Net Cash | -8.59M |
| Retained Earnings | -101.57M |
| Total Assets | 3.73M |
| Working Capital | -15.61M |
Cash Flow
In the last 12 months, operating cash flow was -6.98M and capital expenditures -51K, giving a free cash flow of -7.03M.
| Operating Cash Flow | -6.98M |
| Capital Expenditures | -51K |
| Free Cash Flow | -7.03M |
| FCF Per Share | -0.25 |
Margins
Gross margin is -43.7%, with operating and profit margins of -1493.78% and -1575.27%.
| Gross Margin | -43.7% |
| Operating Margin | -1493.78% |
| Pretax Margin | -1574.96% |
| Profit Margin | -1575.27% |
| EBITDA Margin | -1493.78% |
| EBIT Margin | -1493.78% |
| FCF Margin | -1093.93% |
Dividends & Yields
ONMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for ONMD.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | -51.45 |
| Piotroski F-Score | 3 |